相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Determining Role of Mitochondrial Reactive Oxygen Species Generation and Monoamine Oxidase Activity in Doxorubicin-Induced Cardiotoxicity
Salvatore Antonucci et al.
ANTIOXIDANTS & REDOX SIGNALING (2021)
Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity
Ling He et al.
CARDIOVASCULAR TOXICOLOGY (2021)
Statin Exposure and Risk of Heart Failure After Anthracycline- or Trastuzumab-Based Chemotherapy for Early Breast Cancer: A Propensity Score-Matched Cohort Study
Husam Abdel-Qadir et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy
Panagiotis Efentakis et al.
CARDIOVASCULAR RESEARCH (2020)
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies
Alberto Aimo et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Signaling Pathways Underlying Anthracycline Cardiotoxicity
Valentina Sala et al.
ANTIOXIDANTS & REDOX SIGNALING (2020)
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Kerstin N. Timm et al.
CARDIOVASCULAR DRUGS AND THERAPY (2020)
Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease
Luca Liberale et al.
EUROPEAN HEART JOURNAL (2020)
Exploratory Review of the Role of Statins, Colchicine, and Aspirin for the Prevention of Radiation-Associated Cardiovascular Disease and Mortality
Maria Isabel Camara Planek et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase IIβ Interaction as a Prerequisite for Effective Protection against Anthracycline Cardiotoxicity
Petra Kollarova-Brazdova et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)
Valentina Mercurio et al.
ANTIOXIDANTS (2020)
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Doxorubicin cardiomyopathy is ameliorated by acacetin via Sirt1-mediated activation of AMPK/Nrf2 signal molecules
Wei-Yin Wu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy
Dulguun Amgalan et al.
NATURE CANCER (2020)
Rosuvastatin and simvastatin attenuate cisplatin-induced cardiotoxicity via disruption of endoplasmic reticulum stress-mediated apoptotic death in rats: targeting ER-Chaperone GRP78 and Calpain-1 pathways
Dalia O. Saleh et al.
TOXICOLOGY REPORTS (2020)
Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease
Luca Liberale et al.
EUROPEAN HEART JOURNAL (2020)
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study
F. Lynce et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity
Michele Russo et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Cardioprotective roles of sestrin 1 and sestrin 2 against doxorubicin cardiotoxicity
Ruiting Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2019)
From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview
Carlo Gabriele Tocchetti et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens
Christian Cadeddu Dessalvi et al.
HEART FAILURE REVIEWS (2019)
Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer
Maya Guglin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury JACC Review Topic of the Week
Sean M. Davidson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity
Monica Samuel Avila et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
The Anti-Cancer Multikinase Inhibitor Sorafenib Impairs Cardiac Contractility by Reducing Phospholamban Phosphorylation and Sarcoplasmic Calcium Transients
Christopher Schneider et al.
SCIENTIFIC REPORTS (2018)
Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection
Hans Erik Botker et al.
BASIC RESEARCH IN CARDIOLOGY (2018)
Increased Afterload Augments Sunitinib-Induced Cardiotoxicity in an Engineered Cardiac Microtissue Model
Rachel Truitt et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)
Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity
Edith Pituskin et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
Javier Egea et al.
REDOX BIOLOGY (2017)
Risk of Heart Failure With Preserved Ejection Fraction in Older Women After Contemporary Radiotherapy for Breast Cancer
Hirofumi Saiki et al.
CIRCULATION (2017)
Bidirectional cross-regulation between ErbB2 and β-adrenergic signalling pathways
Polina Sysa-Shah et al.
CARDIOVASCULAR RESEARCH (2016)
Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors
Steven E. Lipshultz et al.
CANCER (2016)
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 x 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
Geeta Gulati et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Jose Luis Zamorano et al.
EUROPEAN HEART JOURNAL (2016)
Cardiovascular Toxic Effects of Targeted Cancer Therapies
Javid J. Moslehi
NEW ENGLAND JOURNAL OF MEDICINE (2016)
ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity
Frances Belmonte et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Protective Mechanisms of Mitochondria and Heart Function in Diabetes
Miguel A. Aon et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Redox signalling and cardioprotection: translatability and mechanism
P. Pagliaro et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Pharmacology of the 'gasotransmitters' NO, CO and H2S: translational opportunities
Andreas Papapetropoulos et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Oxidative stress alters global histone modification and DNA methylation
Yingmei Niu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Redox regulation of genome stability by effects on gene expression, epigenetic pathways and DNA damage/repair
Yuliya Mikhed et al.
REDOX BIOLOGY (2015)
Radiation-induced heart disease: pathologic abnormalites and putative mechanisms
Neil K. Taunk et al.
FRONTIERS IN ONCOLOGY (2015)
Cardiotoxicity of systemic agents used in breast cancer
Felipe Ades et al.
BREAST (2014)
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Yoshihiko Ichikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism
Ioanna Andreadou et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Metformin Protects Cardiomyocyte from Doxorubicin Induced Cytotoxicity through an AMP-Activated Protein Kinase Dependent Signaling Pathway: An In Vitro Study
Laura C. Kobashigawa et al.
PLOS ONE (2014)
Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling
Rimpy Dhingra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors
Carlo G. Tocchetti et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study
Mehmet G. Kaya et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies
Xavier Bosch et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Creatine Kinase-Overexpression Improves Myocardial Energetics, Contractile Dysfunction and Survival in Murine Doxorubicin Cardiotoxicity
Ashish Gupta et al.
PLOS ONE (2013)
Coronary Microvascular Pericytes Are the Cellular Target of Sunitinib Malate-Induced Cardiotoxicity
Vishnu Chintalgattu et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes
Peter P. Rainer et al.
BJU INTERNATIONAL (2012)
Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury
Edouard I. Azzam et al.
CANCER LETTERS (2012)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer Current Evidence and Underlying Mechanisms
Jessica M. Scott et al.
CIRCULATION (2011)
Mechanisms of Antiangiogenic-Induced Arterial Hypertension
Jean-Jacques Mourad et al.
CURRENT HYPERTENSION REPORTS (2011)
Metformin protects against doxorubicin-induced cardiotoxicity: Involvement of the adiponectin cardiac system
Mari C. Asensio-Lopez et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Reduced in vivo high-energy phosphates precede Adriamycin-induced cardiac dysfunction
M. Y. Maslov et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
The Vulnerability of the Heart As a Pluricellular Paracrine Organ Lessons From Unexpected Triggers of Heart Failure in Targeted ErbB2 Anticancer Therapy
Gilles W. De Keulenaer et al.
CIRCULATION RESEARCH (2010)
RADIATION-RELATED HEART DISEASE: CURRENT KNOWLEDGE AND FUTURE PROSPECTS
Sarah C. Darby et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Adjuvant Trastuzumab Induces Ventricular Remodeling Despite Aerobic Exercise Training
Mark J. Haykowsky et al.
CLINICAL CANCER RESEARCH (2009)
Sunitinib-Induced Cardiotoxicity Is Mediated by Off-Target Inhibition of AMP-Activated Protein Kinase
Risto Kerkela et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2009)
Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent Pathways
Leo I. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart
Filomena de Nigris et al.
EUROPEAN JOURNAL OF CANCER (2008)
Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart
Che-Hong Chen et al.
SCIENCE (2008)
Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells
Yvonne Will et al.
TOXICOLOGICAL SCIENCES (2008)
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Tammy F. Chu et al.
LANCET (2007)
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
Thomas M. Suter et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Protective effects of carvedilol against anthracycline-induced cardiomyopathy
Nihat Kalay et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes
Francesco Timolati et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin
Malgorzata Tokarska-Schlattner et al.
COMPTES RENDUS BIOLOGIES (2006)
Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply
M Tokarska-Schlattner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy
C Özcelik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
ErbB2 is essential in the prevention of dilated cardiomyopathy
SA Crone et al.
NATURE MEDICINE (2002)
分享论文
